Alphatec (ATEC) Surges 9.5%: Is This an Indication of Further Gains?

By Zacks Equity Research | January 16, 2026, 2:52 AM

Alphatec ATEC shares soared 9.5% in the last trading session to close at $17.46. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 18.5% loss over the past four weeks.

Alphatec scored a strong price increase, driven by investor’s optimism surrounding its recent announcement of select preliminary financial results for 2025. For the year 2026, the company projects total revenue of $890 million, reflecting growth of approximately 17% compared to the full year 2025. In addition, Alphatec announced the acquisition of exclusive U.S. distribution rights for Theradaptive’s OsteoAdapt, a next-generation rhBMP-2 solution that expands its procedural offerings.

This medical equipment and supplies holding company is expected to post quarterly earnings of $0.04 per share in its upcoming report, which represents a year-over-year change of +117.4%. Revenues are expected to be $212.6 million, up 20.3% from the year-ago quarter.

Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.

For Alphatec, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on ATEC going forward to see if this recent jump can turn into more strength down the road.

The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>

Alphatec is a member of the Zacks Medical - Instruments industry. One other stock in the same industry, Integer ITGR, finished the last trading session 0.7% higher at $85.28. ITGR has returned 14.3% over the past month.

For Integer, the consensus EPS estimate for the upcoming report has remained unchanged over the past month at $1.7. This represents a change of +18.9% from what the company reported a year ago. Integer currently has a Zacks Rank of #3 (Hold).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Alphatec Holdings, Inc. (ATEC): Free Stock Analysis Report
 
Integer Holdings Corporation (ITGR): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Latest News

6 hours
14 hours
Jan-15
Jan-14
Jan-14
Jan-14
Jan-13
Jan-12
Jan-12
Jan-09
Jan-06
Dec-29
Dec-28
Dec-22
Dec-19